Facetten
Zugriff
Einrichtung
Medientyp
- Text 15
Karte
Erscheinungsjahr
Autor/in
- Reich, Kristian
- Augustin, Matthias 4
- Foley, Peter 4
- Thaçi, Diamant 4
- Armstrong, April W 3
- alle zeigen
Sprache
15 Einträge gefunden
-
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis
- Simpson, Eric
- Bissonnette, Robert
- Eichenfield, Lawrence F
- Guttman-Yassky, Emma
- King, Brett
- Silverberg, Jonathan I
- Beck, Lisa A
-
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials
- Leonardi, Craig
- Reich, Kristian
- Foley, Peter
- Torii, Hideshi
- Gerdes, Sascha
- Guenther, Lyn
- Gooderham, Melinda
-
Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care
- da Silva, Neuza Maria Bernardino
- Augustin, Matthias
- Langenbruch, Anna Katharina
- Mrowietz, Ulrich
- Reich, Kristian
- Thaçi, Diamant
- Boehncke, Wolf-Henning
-
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis
- Langley, Richard G B
- Reich, Kristian
- Strand, Vibeke
- Feldman, Steven R
- Paul, Carle
- Gordon, Kenneth
- Warren, Richard B
-
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial
- Reich, Kristian
- Kabashima, Kenji
- Peris, Ketty
- Silverberg, Jonathan I
- Eichenfield, Lawrence F
- Bieber, Thomas
- Kaszuba, Aleksandra
-
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
- Lacour, Jean-Philippe
- Bewley, Anthony
- Hammond, Edward
- Hansen, Jes B
- Horne, Laura
- Paul, Carle
- Reich, Kristian
-
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
- Armstrong, April
- Paul, Carle
- Puig, Luis
- Boehncke, Wolf Henning
- Freeman, Michael
- Torii, Hideshi
- Papp, Kim
-
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials
- Reich, Kristian
- Griffiths, Christopher E M
- Gordon, Kenneth B
- Papp, Kim A
- Song, Michael
- Randazzo, Bruce
- Li, Shu
-
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
- Deleuran, Mette
- Thaçi, Diamant
- Beck, Lisa A
- de Bruin-Weller, Marjolein
- Blauvelt, Andrew
- Forman, Seth
- Bissonnette, Robert
-
-
-
COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen
- Buhl, Timo
- Beissert, Stefan
- Gaffal, Evelyn
- Goebeler, Matthias
- Hertl, Michael
- Mauch, Cornelia
- Reich, Kristian
-
-
-
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care
- da Silva, Neuza Maria Bernardino
- Augustin, Matthias
- Langenbruch, Anna Katharina
- Mrowietz, Ulrich
- Reich, Kristian
- Thaçi, Diamant
- Boehncke, Wolf-Henning